v3.25.2
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Schedule of research and development expenses) (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Supplementary Financial Statement Information [Abstract]        
Payroll and related expenses $ 763 $ 1,000 $ 1,687 $ 1,957
Clinical and preclinical trials expenses 1,850 905 3,660 3,693
Professional consulting and subcontracted work 1,656 214 4,722 1,451
Supplier-led manufacturing development 0 0 2,749 0
Other 377 319 671 682
Total Research and development expenses $ 4,646 $ 2,438 $ 13,489 $ 7,783